Neurohormonal activation in congestive heart failure: does it normalize after heart transplantation? (Q44998991)

8 December 2017

Neurohormonal activation in congestive heart failure: does it normalize after heart transplantation? (English)

1 reference

8 December 2017

congestive heart failure

1 reference

Félix Pérez-Villa

1

1 reference

8 December 2017

Eulalia Roig

2

1 reference

8 December 2017

Elena Ferrer

3

1 reference

8 December 2017

Alfredo Cuppoletti

4

1 reference

8 December 2017

Marcelo Llancaqueo

5

1 reference

8 December 2017

Wladimiro Jiménez

6

1 reference

8 December 2017

Ginés Sanz

7

1 reference

8 December 2017

language of work or name

Spanish

0 references

publication date

1 August 2004

1 reference

Revista Española de Cardiología

8 December 2017

1 reference

8 December 2017

57

1 reference

8 December 2017

8

1 reference

8 December 2017

725-731

1 reference

Prognostic value of cytokines and neurohormones in severe heart failure

8 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

[Prognostic value of serum levels of tumor necrosis factor-alpha in patients with heart failure]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Haemodynamic impact of diuretic therapy in chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Abnormal neuroendocrine responses during exercise in heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Endothelin and heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Effect of cyclosporine on plasma endothelin levels in humans after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Is increased circulating endothelin associated with increased complication rate after heart transplantation?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Circulating adrenomedullin is increased after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

[Analysis of factors that can influence the appearance of acute heart transplant failure]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Breakdown of blood pressure and body fluid homeostasis in heart transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

High dose angiotensin-converting enzyme inhibition prevents fluid volume expansion in heart transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

High-dose angiotensin-converting enzyme inhibition restores body fluid homeostasis in heart-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Impairment in forearm endothelium-dependent vasodilation after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: reduction of incidence and severity of transplant vasculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977182-1

7 January 2021

10.1016/S0300-8932(04)77182-1

Identifiers

DOI

1 reference

8 December 2017

1 reference